Yong Ba’s research group is interested in both basic research and developing intellectual properties in the area of biomedical materials and methods including free radical labeled anticancer drugs, controlled release hydrogels, cyclodextrin based drug delivery molecular carriers, biocompatible nanoparticles, and spin labeled and functionally valued antifreeze proteins and other biomedical proteins.